|
Originally published In Press as doi:10.1074/jbc.M304034200 on September 22, 2003
J. Biol. Chem., Vol. 278, Issue 49, 49279-49285, December 5, 2003
Terpene Trilactones from Ginkgo biloba Are Antagonists of Cortical Glycine and GABAA Receptors*
Lidija Ivic ,
Tristan T. J. Sands ,
Nathan Fishkin¶,
Koji Nakanishi¶,
Arnold R. Kriegstein ||, and
Kristian Strømgaard¶**
From the
Department of Neurology, College of Physicians & Surgeons and the Integrated Program in Cellular, Molecular and Biophysical Studies, Columbia University, New York, New York 10032 and the ¶Department of Chemistry, Columbia University, New York, New York 10027
Glycine and -aminobutyric acid, type A (GABAA) receptors are members of the ligand-gated ion channel superfamily that mediate inhibitory synaptic transmission in the adult central nervous system. During development, the activation of these receptors leads to membrane depolarization. Ligands for the two receptors have important implications both in disease therapy and as pharmacological tools. Terpene trilactones (ginkgolides and bilobalide) are unique constituents of Ginkgo biloba extracts that have various effects on the central nervous system. We have investigated the relative potency of these compounds on glycine and GABAA receptors. We find that most of the ginkgolides are selective and potent antagonists of the glycine receptor. Bilobalide, the single major component in G. biloba extracts, also reduces glycine-induced currents, although to a lesser extent. Both ginkgolides and bilobalide inhibit GABAA receptors, with bilobalide demonstrating a more potent effect. Additionally, we provide evidence that open channels are required for glycine receptor inhibition by ginkgolides. Finally, we employ molecular modeling to elucidate the similarities and differences in the structure of the terpene trilactones to account for the pharmacological properties of these compounds and demonstrate a striking similarity between ginkgolides and picrotoxinin, a GABAA and recombinant glycine -homomeric receptor antagonist.
Received for publication, April 17, 2003
, and in revised form, September 18, 2003.
* This research was supported by National Institutes of Health Grant NS 38658 and the Alfred Benzon Foundation (to K. S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
** Present address: Dept. of Medicinal Chemistry, The Danish University of Pharmaceutical Sciences, Universitetsparken 2, DK-2100 Copenhagen, Denmark.
|| To whom correspondence should be addressed. Tel.: 212-305-4275; Fax: 212-305-3986; E-mail: ark17{at}columbia.edu.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
Y. Wu, Z. Wu, P. Butko, Y. Christen, M. P. Lambert, W. L. Klein, C. D. Link, and Y. Luo
Amyloid-{beta}-Induced Pathological Behaviors Are Suppressed by Ginkgo biloba Extract EGb 761 and Ginkgolides in Transgenic Caenorhabditis elegans
J. Neurosci.,
December 13, 2006;
26(50):
13102 - 13113.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Hawthorne and J. W. Lynch
A Picrotoxin-specific Conformational Change in the Glycine Receptor M2-M3 Loop
J. Biol. Chem.,
October 28, 2005;
280(43):
35836 - 35843.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. W. Lynch
Molecular Structure and Function of the Glycine Receptor Chloride Channel
Physiol Rev,
October 1, 2004;
84(4):
1051 - 1095.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2003 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|